Galactose for Interference Testing

• Description:

  Galactose for Interference Testing_x000D_ Catalog number: C2010416_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 500 mg_x000D_ Molecular Weight or Concentration: 180.16 g/mol_x000D_ Supplied as: Powder_x000D_ Appearance: White solid_x000D_ Applications: simple monosaccharide that can be used as an energy source as well as a component of glycolipids and glycoproteins._x000D_ Storage: Room Temperature_x000D_ Keywords: D-(+)-Galactose, D-galactose_x000D_ Grade: Biotechnology grade. All solid components are highly pure (minimum 95%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Boehm R, Donovan J, Sheth D, Durfor A, Roberts J, Isayeva I. In Vitro Sugar_x000D_ Interference Testing With Amperometric Glucose Oxidase Sensors. J Diabetes Sci_x000D_ Technol. 2019 Jan;13(1):82-95._x000D_ _x000D_ 2: Ng WY, Tiong CC, Jacob E. Maltose interference-free test strips for blood_x000D_ glucose testing at point-of-care: a laboratory performance evaluation. Diabetes_x000D_ Technol Ther. 2010 Nov;12(11):889-93._x000D_ _x000D_ 3: Ceriotti F, Kaczmarek E, Guerra E, Mastrantonio F, Lucarelli F, Valgimigli F,_x000D_ Mosca A. Comparative performance assessment of point-of-care testing devices for_x000D_ measuring glucose and ketones at the patient bedside. J Diabetes Sci Technol._x000D_ 2015 Mar;9(2):268-77._x000D_ _x000D_ 4: Schleis TG. Interference of maltose, icodextrin, galactose, or xylose with_x000D_ some blood glucose monitoring systems. Pharmacotherapy. 2007 Sep;27(9):1313-21._x000D_ _x000D_ 5: Paigen K, Pacholec F, Levy HL. A new method of screening for inherited_x000D_ disorders of galactose metabolism. J Lab Clin Med. 1982 Jun;99(6):895-907._x000D_ _x000D_ 6: Ba Y, Xu J, Yuan L, Zhu H, Yang Y, Lam MM, Zhang S, Xiao M, Xu J, Zhang R,_x000D_ Chen C. Assessment of the performance of blood glucose monitoring systems for_x000D_ monitoring dysglycaemia in neonatal patients. BMJ Paediatr Open. 2018 Oct_x000D_ 23;2(1):e000339._x000D_ _x000D_ 7: Sicard C, Shek N, White D, Bowers RJ, Brown RS, Brennan JD. A rapid and_x000D_ sensitive fluorimetric β-galactosidase assay for coliform detection using_x000D_ chlorophenol red-β-D-galactopyranoside. Anal Bioanal Chem. 2014_x000D_ Sep;406(22):5395-403._x000D_ _x000D_ 8: McDougall GJ, Fry SC. Structure-activity relationships for xyloglucan_x000D_ oligosaccharides with antiauxin activity. Plant Physiol. 1989 Mar;89(3):883-7._x000D_ 9: Lee YK, Puong KY. Competition for adhesion between probiotics and human_x000D_ gastrointestinal pathogens in the presence of carbohydrate. Br J Nutr. 2002_x000D_ Sep;88 Suppl 1:S101-8. _x000D_ _x000D_ Products Related to Galactose for Interference Testing : Interference

• Short Description:

  Catalog Number: C2010416 (500 mg)

• Weight:

  0.8

• Length:

  2

• Width:

  0.9

• Height:

  0.9

• Height :

  0.9